Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 20

Sort by

Sort Order Select

Journal Articles

Impact of Osseous and Non-Osseous Extramedullary Disease in Multiple Myeloma: Clinical Characteristics and Outcomes in a Latin American Population

Cesar Vargas-Serafin, MD, Aldo A Acosta-Medina, MS, Juan Rangel-Patiño, MD, Daniela Perez-Samano, MD, Deborah M. Martinez-Banos, Christianne Bourlon, MD

Blood (2019) 134 (Supplement_1): 5527.

https://doi.org/10.1182/blood-2019-128791

Published: 2019

Journal Articles

Complete Responses of Myeloid/Lymphoid Neoplasms with Rearrangement of Pdgfra Presenting As AML/ALL/Myeloid Sarcoma to Imatinib Monotherapy

Rui MA, Jinsong Jia, MD, Jun Kong, MD, Xiaojun Huang, Hao Jiang, MD

Blood (2017) 130 (Supplement 1): 5027.

https://doi.org/10.1182/blood.V130.Suppl_1.5027.5027

Published: 2017

Journal Articles

Phase Ib Study of Isatuximab and Carfilzomib in Relapse and Refractory Multiple Myeloma

Thomas G. Martin, III, MD, Gabriel N Mannis, Ajai Chari, MD, Pamela Munster, MD, Frank Campana, MD, Ai-Min Hui, MD PhD, Jeffrey L. Wolf, MD

Blood (2016) 128 (22): 2111.

https://doi.org/10.1182/blood.V128.22.2111.2111

Published: 2016

Journal Articles

Detection of Circulating Plasma Cells in Multiple Myeloma with Extramedullary Plasmacytoma

Jing Wang, Shuang Geng, Yuping Zhong, MD, Mingyi Chen, MD PhD, Wenming Wang, Yuhong Pang, PhD, Jiajia Zhang, Yuanyuan Liu, Yanyi Huang, PhD, Hongmei Jing, MD

Blood (2015) 126 (23): 5328.

https://doi.org/10.1182/blood.V126.23.5328.5328

Published: 2015

Journal Articles

Outcomes of Autologous Transplants for Patients with Multiple Myeloma and Concurrent Multiple Plasmacytomas

Seema Naik, MD, Paul J. Shaughnessy, MD, Behyar Zoghi, MDPhD, Jose C Cruz, MD, Carlos Bachier, MD

Blood (2015) 126 (23): 1973.

https://doi.org/10.1182/blood.V126.23.1973.1973

Published: 2015

Journal Articles

Second Cancers After Treatment with Stanford V Regimen in Eastern Cooperative Oncology Group (ECOG) Pilot Study E1492 At a Median Follow up of 17 Years

Ranjana H. Advani, MD, Hailun Li, MS, Richard T. Hoppe, MD, Nancy L. Bartlett, MD, John M. Bennett, MD, Donna S. Neuberg, ScD, Peter A Cassileth, MD, Brad S. Kahl, M.D., Sandra J. Horning, M.D.

Blood (2012) 120 (21): 4779.

https://doi.org/10.1182/blood.V120.21.4779.4779

Published: 2012

Journal Articles

Long Term Survival After High-Dose Chemotherapy with Autologous Hematopoietic Cell Transplantation in Metastatic Breast Cancer.

Betty K. Hamilton, MD, Brian J. Bolwell, MD, Lisa Rybicki, MS, Shawnda Tench, Matt Kalaycio, MD, Steven Andresen, DO, Robert M Dean, MD, Ronald Sobecks, MD, Brad Pohlman, MD, Brian T. Hill, MD, PhD, Rabi Hanna, MD, Hien K. Duong, MD, Edward A. Copelan, MD

Blood (2012) 120 (21): 3072.

https://doi.org/10.1182/blood.V120.21.3072.3072

Published: 2012

Journal Articles

Post-Transplant Lymphoproliferative Disorder in Lung Transplant Recipients – a Shift Lo Late Onset Disease

Eli Muchtar, MD, Liat Vidal, MD, Ron Ram, MD, Ronit Gurion, MD, Yivgenia Rosenblat, MD, Ilana Bakal, RN, Mordechai Kramer, MD, FCCP, Ofer Shpilberg, MD, MPH

Blood (2012) 120 (21): 5075.

https://doi.org/10.1182/blood.V120.21.5075.5075

Published: 2012

Journal Articles

Regression of Adult T-Cell Leukemia with Anti-CD25 Recombinant Immunotoxin LMB-2 Preceded by Chemotherapy

Robert J. Kreitman, MD, Rajat Singh, Maryalice Stetler-Stevenson, MD, PhD, Thomas A. Waldmann, MD, Ira Pastan, MD

Blood (2011) 118 (21): 2575.

https://doi.org/10.1182/blood.V118.21.2575.2575

Published: 2011

Journal Articles

Evaluation of the Toxicity of Total Body Irradation As a Separate Treatment in Preparation for Hematopoietic Cell Transplantation

Sebastian Giebel, MD, Tomasz Kruzel, Maria Sadus-Wojciechowska, MD, Jacek Najda, MD, Tomasz Czerw, MD, Leszek Miszczyk, MD, PhD, Jerzy Holowiecki, MD, PhD

Blood (2011) 118 (21): 4579.

https://doi.org/10.1182/blood.V118.21.4579.4579

Published: 2011

Journal Articles

Pre-Surgical Methylene-Blue “targeting” of Small Intrapulmonary Nodules In Patients with Haematological Malignancies: Preliminary Experience.

M. Mansour Ceesay, MRCP, FRCPath, Ouni Jaffer, Phillip FC Lung, Michael T Marrinan, Ranjit Deshpande, Nicola Mullholland, Antonio Pagliuca, MBBS, FRCP, FRCPath, MA, Ghulam J. Mufti, DM, FRCP, FRCPath, Sujal R Desai, MBBS, MD, FRCR

Blood (2010) 116 (21): 4551.

https://doi.org/10.1182/blood.V116.21.4551.4551

Published: 2010

Journal Articles

Increased Incidence of Extramedullary Plasmacytomas In Patients with Multiple Myeloma In the Era of Novel Therapy and Effect of Pomalidomide on Extramedullary Disease

Kristen Detweiler Short, RN, CNP, S. Vincent Rajkumar, MD, Francis Buadi, MD, Dirk Larson, Suzanne R. Hayman, MD, Angela Dispenzieri, MD, Morie Abraham A Gertz, MD, Shaji Kumar, MD, Joseph R. Mikhael, MD, Vivek Roy, Robert Kyle, MD, Martha Lacy, MD

Blood (2010) 116 (21): 3047.

https://doi.org/10.1182/blood.V116.21.3047.3047

Published: 2010

Journal Articles

Transplantation Following Myeloablative Cytoreduction Results in Excellent Survival, Long-Term Engraftment, and Donor Chimerism in Children with Chronic Granulomatous Disease Across Donor and Graft Sources.

Priti Tewari, MD, Susan Wood, PNP, Paul L Martin, MD, PhD, Suhag H Parikh, MD, Paul Szabolcs, MD, Kristin M Page, MD, Timothy Driscoll, MD, Joanne Kurtzberg, MD, Vinod K. Prasad, MBBS, MD, MRCP,

Blood (2009) 114 (22): 3398.

https://doi.org/10.1182/blood.V114.22.3398.3398

Published: 2009

Journal Articles

Autologous Transplantation Is the Optimum Approach to the Management of Myeloma Patients with Extramedullary Disease at Presentation

Faith E. Davies, Ping Wu, Kevin Boyd, Radovan Saso, Michael N Potter, Mark E Ethell, Bronwen E Shaw, Jenny Treleaven, Sharon Dines, Gareth J Morgan

Blood (2008) 112 (11): 3313.

https://doi.org/10.1182/blood.V112.11.3313.3313

Published: 2008

Journal Articles

Deep Venous Thrombosis Screening of Hemophilia Patients with Central Venous Catheters.

Carrye R. Cost, MD, Kim L. Spencer, MS, RN, CPNP, George R. Buchanan, MD, Janna M. Journeycake, MD

Blood (2008) 112 (11): 2282.

https://doi.org/10.1182/blood.V112.11.2282.2282

Published: 2008

Journal Articles

Meningeal Dissemination (MD) in Primary CNS Lymphoma (PCNSL): Multimodal Diagnosis, Presentation and Outcome in a Large Monocenter Patient Cohort

Philipp Kiewe, Agnieszka Korfel, Lars Fischer, Peter Martus, Eckhard Thiel

Blood (2008) 112 (11): 5300.

https://doi.org/10.1182/blood.V112.11.5300.5300

Published: 2008

Journal Articles

Radiation Recall Dermatitis after Bortezomib Therapy.

Alpesh J. Amin, MD, Michael Maroules, MD

Blood (2006) 108 (11): 5103.

https://doi.org/10.1182/blood.V108.11.5103.5103

Published: 2006

Journal Articles

Pediatric Norms for Assessment of Upper Venous Post-Thrombotic Syndrome.

Beth M. Boulden, MS, Shelley E. Crary, MD, George R. Buchanan, MD, Janna M. Journeycake, MD

Blood (2005) 106 (11): 4112.

https://doi.org/10.1182/blood.V106.11.4112.4112

Published: 2005

Journal Articles

SGN-30 (Anti-CD30 Monoclonal Antibody) Is Active and Well Tolerated in Patients with Refractory or Recurrent Systemic Anaplastic Large Cell Lymphoma.

Andres Forero-Torres, Steven Bernstein, Ajay Gopal, Francine Foss, John Leonard, Joseph Rosenblatt, Nancy Bartlett, Anas Younes, David Fisher, Bruce Cheson, Matthew Carabasi, Gregory Bociek, Bruce Hart, Michael McDonald

Blood (2004) 104 (11): 2637.

https://doi.org/10.1182/blood.V104.11.2637.2637

Published: 2004

Journal Articles

V H gene analysis of splenic marginal zone lymphomas reveals diversity in mutational status and initiation of somatic mutation in vivo

Delin Zhu, Jennifer Orchard, David G. Oscier, Dennis H. Wright, Freda K. Stevenson

Blood (2002) 100 (7): 2659–2661.

https://doi.org/10.1182/blood-2002-01-0169

Published: 2002

NARROW

Impact of Osseous and Non-Osseous Extramedullary Disease in Multiple Myeloma: Clinical Characteristics and Outcomes in a Latin American Population

Complete Responses of Myeloid/Lymphoid Neoplasms with Rearrangement of Pdgfra Presenting As AML/ALL/Myeloid Sarcoma to Imatinib Monotherapy

Phase Ib Study of Isatuximab and Carfilzomib in Relapse and Refractory Multiple Myeloma

Detection of Circulating Plasma Cells in Multiple Myeloma with Extramedullary Plasmacytoma

Outcomes of Autologous Transplants for Patients with Multiple Myeloma and Concurrent Multiple Plasmacytomas

Second Cancers After Treatment with Stanford V Regimen in Eastern Cooperative Oncology Group (ECOG) Pilot Study E1492 At a Median Follow up of 17 Years

Long Term Survival After High-Dose Chemotherapy with Autologous Hematopoietic Cell Transplantation in Metastatic Breast Cancer.

Post-Transplant Lymphoproliferative Disorder in Lung Transplant Recipients – a Shift Lo Late Onset Disease

Regression of Adult T-Cell Leukemia with Anti-CD25 Recombinant Immunotoxin LMB-2 Preceded by Chemotherapy

Evaluation of the Toxicity of Total Body Irradation As a Separate Treatment in Preparation for Hematopoietic Cell Transplantation

Pre-Surgical Methylene-Blue “targeting” of Small Intrapulmonary Nodules In Patients with Haematological Malignancies: Preliminary Experience.

Increased Incidence of Extramedullary Plasmacytomas In Patients with Multiple Myeloma In the Era of Novel Therapy and Effect of Pomalidomide on Extramedullary Disease

Transplantation Following Myeloablative Cytoreduction Results in Excellent Survival, Long-Term Engraftment, and Donor Chimerism in Children with Chronic Granulomatous Disease Across Donor and Graft Sources.

Autologous Transplantation Is the Optimum Approach to the Management of Myeloma Patients with Extramedullary Disease at Presentation

Deep Venous Thrombosis Screening of Hemophilia Patients with Central Venous Catheters.

Meningeal Dissemination (MD) in Primary CNS Lymphoma (PCNSL): Multimodal Diagnosis, Presentation and Outcome in a Large Monocenter Patient Cohort

Radiation Recall Dermatitis after Bortezomib Therapy.

Pediatric Norms for Assessment of Upper Venous Post-Thrombotic Syndrome.

SGN-30 (Anti-CD30 Monoclonal Antibody) Is Active and Well Tolerated in Patients with Refractory or Recurrent Systemic Anaplastic Large Cell Lymphoma.

V H gene analysis of splenic marginal zone lymphomas reveals diversity in mutational status and initiation of somatic mutation in vivo

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only